| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OPTIMA MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,362 | -1,00 % | Curaleaf Holdings, Inc.: Curaleaf Responds to Aurora Cannabis Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders | Highlights
Curaleaf Offers a 45% Premium and Meaningful Future Upside: Aurora shareholders can realize immediate value alongside the opportunity to participate... ► Artikel lesen | |
| CANOPY GROWTH | 0,834 | +0,05 % | Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. | ||
| TILRAY BRANDS | 3,880 | +0,26 % | Tilray Brands, Inc.: Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves | Fresh from multiple wins at the 2026 World Beer Awards, BrewDog brings a major new premium craft beer innovation to market through a nationwide retail rollout.
Four art-led beers, big hop character... ► Artikel lesen | |
| ABBOTT LABORATORIES | 91,74 | -1,63 % | Gewinner der Börsengeschichte: +3.923.693 % Rendite und ein Top ESG-Score? Ja, das geht! | © Foto: Frank Rumpenhorst - dpaNachhaltigkeit und eine hohe Rendite schließen sich nicht aus. Im Gegenteil: Diese ESG-Aktie schaffte es unter die Top 30 der US-Aktien mit der höchsten Buy-and-Hold-Rendite... ► Artikel lesen | |
| SINOPHARM | 1,760 | +2,53 % | SINOPHARM (01099): FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDAY, 15 SEPTEMBER 2026 | ||
| AMARIN | 11,700 | -0,85 % | Amarin Corporation plc: Amarin Highlights New REDUCE-IT and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026 | ||
| ACADIA PHARMACEUTICALS | 23,920 | +0,50 % | Acadia Pharmaceuticals Inc.: Europäische Kommission erteilt Zulassung für DAYBU (Trofinetid) als erste und einzige Therapie für neurobehaviorale Symptome des Rett-Syndroms in der Europäischen Union | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) hat heute bekannt gegeben, dass die Europäische Kommission (EK) die Marktzulassung für DAYBU (Trofinetid) zur Behandlung neurobehavioraler Symptome des Rett-Syndroms... ► Artikel lesen | |
| BRIDGEBIO PHARMA | 63,96 | -0,71 % | H.C. Wainwright reiterates Buy on BridgeBio stock on trial data | ||
| AURINIA PHARMACEUTICALS | 13,985 | +1,01 % | Alliance Advisors LLC: Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences | Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratulate Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) on the successful completion of its tender offer... ► Artikel lesen | |
| CNBX PHARMACEUTICALS | - | - | CNBX Pharmaceuticals Inc. - 10-Q, Quarterly Report | ||
| ARGENT BIOPHARMA | 0,011 | 0,00 % | ARGENT BIOPHARMA LIMITED: Notification of cessation of securities - RGT | ||
| CENTR BRANDS | 0,001 | 0,00 % | Centr Brands Corp (2): Centr Brands extends maturity dates of debentures | ||
| LABORATORIOS FARMACEUTICOS ROVI | 58,80 | -1,01 % | Dividendenbekanntmachungen (13.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AS COMPANY SA GRS404003006 - 0,1919 EUR BANK OZK US06417N1037 0,48 USD 0,4204 EUR BEACON MINERALS LIMITED AU000000BCN0 0,1 AUD 0... ► Artikel lesen | |
| AVECHO BIOTECHNOLOGY | 0,013 | -100,00 % | Avecho Biotechnology Restarts Final Recruitment Stage for Key Insomnia Trial | ||
| HERON THERAPEUTICS | 0,299 | +1,36 % | Heron Therapeutics, Inc.: U.S. District Court Issues Decision Regarding CINVANTI Patents | CARY, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court... ► Artikel lesen |